Skip to main content
Clinical Trials/NCT05698069
NCT05698069
Completed
Not Applicable

Reliability and Validity of the Turkish Version of the Pain Modulation Index

Ege University1 site in 1 country125 target enrollmentFebruary 1, 2022
ConditionsChronic Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Ege University
Enrollment
125
Locations
1
Primary Endpoint
Validity of the Turkish version of Pain Modulation Index
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In order to assess the validity and reliability of the Turkish version of Pain Modulation Index, 125 volunteers with chronic pain were enrolled in the study. Test and re-test method was used to assess reliability and correlation analyses with Pain Detect, visual analog scale pain and central sensitization inventory scores were used to assess validity of the questionnaire. Turkish version of the Pain Modulation Index was found to be a valid and reliable tool for evaluating chronic pain.

Detailed Description

Pain Modulation Index is a questionnaire that was developed in English for the assessment of chronic pain for qualities consistent with central sensitization. The English version of the questionnaire was translated into Turkish by two physicians than back translated into English by two separate bilingual translators. Initially 10 volunteers were asked to answer this first version of the questionnaire and report any difficulties in understanding the items. Their feedback was used to give the questionnaire its final shape. For the validation stage, patients that were diagnosed as having chronic non-cancer pain with more than 3 months duration were enrolled into the study. They answered the questions twice, 15 days apart. In addition to the Turkish version of the Pain Modulation Index, on the first visit, they were also asked to answer Pain Detect and Central Sensitization Inventory. Their answers were analysed to assess the validity and reliability of the Turkish version of Pain Modulation Index.

Registry
clinicaltrials.gov
Start Date
February 1, 2022
End Date
January 5, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ece Cinar

Assistant Professor

Ege University

Eligibility Criteria

Inclusion Criteria

  • presence of chronic non-cancer pain of more than 3 months duration

Exclusion Criteria

  • Illiteracy
  • Refusal to take part in the study

Outcomes

Primary Outcomes

Validity of the Turkish version of Pain Modulation Index

Time Frame: 1 day

Index scores were analysed for their correlation with Pain Detect and Central Sensitization Inventory scores.

Reliability of the Turkish version of pain modulation index

Time Frame: 15 days

Internal consistency was evaluated by test retest method and calculating the coefficient alpha (α) or Cronbach's coefficient, and if the Cronbach's coefficient value was greater than 0.7, it was considered as an acceptable internal consistency

Study Sites (1)

Loading locations...

Similar Trials